You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Cancer immunotherapy trials: leading a paradigm shift in drug development
|
|---|---|
| Published in |
Journal for Immunotherapy of Cancer, July 2016
|
| DOI | 10.1186/s40425-016-0146-9 |
| Pubmed ID | |
| Authors |
Leisha A. Emens, Lisa H. Butterfield, F. Stephen Hodi, Francesco M. Marincola, Howard L. Kaufman |
X Demographics
The data shown below were collected from the profiles of 17 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 35% |
| Ireland | 2 | 12% |
| Canada | 1 | 6% |
| Unknown | 8 | 47% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 10 | 59% |
| Practitioners (doctors, other healthcare professionals) | 4 | 24% |
| Scientists | 2 | 12% |
| Science communicators (journalists, bloggers, editors) | 1 | 6% |
Mendeley readers
The data shown below were compiled from readership statistics for 82 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Norway | 1 | 1% |
| Unknown | 81 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 14 | 17% |
| Researcher | 13 | 16% |
| Student > Ph. D. Student | 12 | 15% |
| Student > Master | 10 | 12% |
| Student > Bachelor | 7 | 9% |
| Other | 14 | 17% |
| Unknown | 12 | 15% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 13 | 16% |
| Agricultural and Biological Sciences | 12 | 15% |
| Biochemistry, Genetics and Molecular Biology | 11 | 13% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 9% |
| Immunology and Microbiology | 4 | 5% |
| Other | 19 | 23% |
| Unknown | 16 | 20% |
Attention Score in Context
This research output has an Altmetric Attention Score of 476. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 October 2017.
All research outputs
#56,087
of 25,373,627 outputs
Outputs from Journal for Immunotherapy of Cancer
#8
of 3,421 outputs
Outputs of similar age
#1,183
of 377,270 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#2
of 13 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 99th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,421 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one has done particularly well, scoring higher than 99% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 377,270 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 99% of its contemporaries.
We're also able to compare this research output to 13 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 84% of its contemporaries.